Biotechnology Research Center, Department of Molecular Medicine, Pasteur Institute of Iran, Tehran, Iran.
Arch Iran Med. 2013 Apr;16(4):217-20.
Thalassemia, which may be due to point mutations, translocations, and deletions involving the α or βglobin gene, is the most prevalent single gene disorder in Iran.This study aims to calculate the α/β ratio in normal cases, α- and β-thalassemia carriers by RT-PCR, real-time PCR, and in vitro globin chain synthesis (GCS) in order to establish the most accurate technique to distinguish between α- and β-thalassemia carriers in suspicious cases.
The α/β ratios were calculated in all samples by RT-PCR, real-time RT-PCR, and in vitro GCS.
Using RT-PCR, the ratios were 1.09 ± 0.07 in normal samples, 1.2 ± 0.17 in β-thalassemia, 1.08 ± 0.19 in mild α-thalassemia, and 0.96 ± 0.19 in severe α-thalassemia carriers. In real-time RT-PCR, the ratios were 2.21 ± 1.36 in normal samples, 5.12 ± 1.83 in β-thalassemia, 2.88 ± 0.81 in mild α-thalassemia, and 1.18 ± 0.52 in severe α-thalassemia carriers. With GCS, the ratios were 1.03 ± 0.1 in normal samples, 1.9 ± 0.37 in β-thalassemia, 0.8 ± 0.13 in mild α-thalassemia, and 0.59 ± 0.12 in severe α-thalassemia carriers.
To determine the most accurate technique, we statistically analyzed the α/β ratios obtained from the three standard methods. The ratio obtained by GCS and real-time PCR were helpful in distinguishing between α and β carriers in suspicious patients in whom the mutation detection was limited and the risk for offspring was not clear. The use of this technique is more obvious when time is restricted (i.e. during the pregnancy period).
地中海贫血症可能是由于涉及α或β球蛋白基因的点突变、易位和缺失引起的,是伊朗最常见的单基因疾病。本研究旨在通过 RT-PCR、实时 PCR 和体外珠蛋白链合成(GCS)计算正常情况下、α-和β-地中海贫血携带者的α/β 比值,以建立区分可疑病例中α-和β-地中海贫血携带者的最准确技术。
通过 RT-PCR、实时 RT-PCR 和体外 GCS 计算所有样本的α/β 比值。
使用 RT-PCR,正常样本的比值为 1.09 ± 0.07,β-地中海贫血样本的比值为 1.2 ± 0.17,轻度α-地中海贫血样本的比值为 1.08 ± 0.19,重度α-地中海贫血携带者的比值为 0.96 ± 0.19。在实时 RT-PCR 中,正常样本的比值为 2.21 ± 1.36,β-地中海贫血样本的比值为 5.12 ± 1.83,轻度α-地中海贫血样本的比值为 2.88 ± 0.81,重度α-地中海贫血携带者的比值为 1.18 ± 0.52。使用 GCS,正常样本的比值为 1.03 ± 0.1,β-地中海贫血样本的比值为 1.9 ± 0.37,轻度α-地中海贫血样本的比值为 0.8 ± 0.13,重度α-地中海贫血携带者的比值为 0.59 ± 0.12。
为了确定最准确的技术,我们对三种标准方法获得的α/β 比值进行了统计学分析。在突变检测有限且不清楚后代风险的可疑患者中,GCS 和实时 PCR 获得的比值有助于区分α 和β 携带者。当时间受限(例如在怀孕期间)时,该技术的使用更加明显。